# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
0, Journal, 0, 21, "Cardiovasc Diabetol .", "", "<http://ctro/data#Publication_76341> <http://ctro/data#hasJournal> \"Cardiovasc Diabetol .\"."
1, PublicationYear, 22, 26, "2017", "", "<http://ctro/data#Publication_76341> <http://ctro/data#hasPublicationYear> \"2017\"."
16, Title, 97, 280, "The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters : a randomized , controlled trial ( Sapporo Athero - Incretin Study 3 ) .", "", "<http://ctro/data#Publication_76341> <http://ctro/data#hasTitle> \"The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters : a randomized , controlled trial ( Sapporo Athero - Incretin Study 3 ) .\"."
2, Vildagliptin, 112, 124, "vildagliptin", "", 
8, Metformin, 139, 148, "metformin", "", 
15, Randomized, 211, 221, "randomized", "", "<http://ctro/data#ClinicalTrial_76348> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
17, Author, 281, 288, "Kitao N", "", "<http://ctro/data#Publication_76341> <http://ctro/data#hasAuthor> \"Kitao N\"."
18, Author, 297, 306, "Miyoshi H", "", "<http://ctro/data#Publication_76341> <http://ctro/data#hasAuthor> \"Miyoshi H\"."
19, Author, 315, 325, "Furumoto T", "", "<http://ctro/data#Publication_76341> <http://ctro/data#hasAuthor> \"Furumoto T\"."
20, Author, 340, 345, "Ono K", "", "<http://ctro/data#Publication_76341> <http://ctro/data#hasAuthor> \"Ono K\"."
21, Author, 354, 362, "Nomoto H", "", "<http://ctro/data#Publication_76341> <http://ctro/data#hasAuthor> \"Nomoto H\"."
22, Author, 371, 377, "Miya A", "", "<http://ctro/data#Publication_76341> <http://ctro/data#hasAuthor> \"Miya A\"."
23, Author, 386, 396, "Yamamoto C", "", "<http://ctro/data#Publication_76341> <http://ctro/data#hasAuthor> \"Yamamoto C\"."
24, Author, 405, 412, "Inoue A", "", "<http://ctro/data#Publication_76341> <http://ctro/data#hasAuthor> \"Inoue A\"."
25, Author, 421, 431, "Tsuchida K", "", "<http://ctro/data#Publication_76341> <http://ctro/data#hasAuthor> \"Tsuchida K\"."
26, Author, 440, 447, "Manda N", "", "<http://ctro/data#Publication_76341> <http://ctro/data#hasAuthor> \"Manda N\"."
27, Author, 456, 466, "Kurihara Y", "", "<http://ctro/data#Publication_76341> <http://ctro/data#hasAuthor> \"Kurihara Y\"."
158, Author, 475, 481, "Aoki S", "", "<http://ctro/data#Publication_76341> <http://ctro/data#hasAuthor> \"Aoki S\"."
29, Author, 490, 500, "Nakamura A", "", "<http://ctro/data#Publication_76341> <http://ctro/data#hasAuthor> \"Nakamura A\"."
30, Author, 509, 517, "Atsumi T", "", "<http://ctro/data#Publication_76341> <http://ctro/data#hasAuthor> \"Atsumi T\"."
63, Author, 561, 570, "Edagawa Y", "", 
31, Author, 573, 579, "Oita M", "", 
32, Author, 582, 589, "Kondo A", "", 
33, Author, 592, 603, "Takahashi K", "", 
34, Author, 606, 616, "Sugawara H", "", 
35, Author, 619, 632, "Dan - Noura M", "", 
36, Author, 635, 643, "Takano Y", "", 
37, Author, 646, 653, "Kitao N", "", 
38, Author, 656, 668, "Koyanagawa N", "", 
39, Author, 671, 677, "Miya A", "", 
40, Author, 680, 690, "Yamamoto K", "", 
41, Author, 693, 703, "Yamamoto C", "", 
42, Author, 706, 714, "Nomoto H", "", 
43, Author, 717, 725, "Kameda Y", "", 
44, Author, 728, 734, "Cho KY", "", 
45, Author, 737, 747, "Nakamura A", "", 
46, Author, 750, 759, "Miyoshi H", "", 
47, Author, 762, 770, "Atsumi T", "", 
48, Author, 773, 783, "Watanabe T", "", 
49, Author, 786, 797, "Takahashi K", "", 
50, Author, 800, 812, "Koyanagawa N", "", 
51, Author, 815, 821, "Kito K", "", 
52, Author, 824, 834, "Yamamoto C", "", 
53, Author, 837, 843, "Endo M", "", 
54, Author, 846, 856, "Takeuchi J", "", 
55, Author, 859, 866, "Nagai S", "", 
56, Author, 869, 877, "Masuda H", "", 
57, Author, 880, 887, "Inoue A", "", 
58, Author, 890, 895, "Ono Y", "", 
59, Author, 898, 908, "Tsuchida K", "", 
60, Author, 911, 918, "Manda N", "", 
61, Author, 921, 931, "Kurihara Y", "", 
62, Author, 934, 940, "Aoki S", "", 
64, Japan, 1146, 1151, "Japan", "", 
65, Japan, 1336, 1341, "Japan", "", 
66, Japan, 1471, 1476, "Japan", "", 
67, Japan, 1585, 1590, "Japan", "", 
68, Japan, 1690, 1695, "Japan", "", 
69, Japan, 1778, 1783, "Japan", "", 
70, Japan, 1828, 1833, "Japan", "", 
71, Japan, 1870, 1875, "Japan", "", 
72, Japan, 1908, 1913, "Japan", "", 
175, ObjectiveDescription, 1929, 2135, "Dipeptidyl peptidase - 4 ( DPP - 4 ) inhibitors may have protective effects in the early stage of atherosclerosis in patients with type 2 diabetes , although similar effects in advanced atherosclerosis were", "", "<http://ctro/data#ClinicalTrial_76348> <http://ctro/data#hasObjectiveDescription> \"Dipeptidyl peptidase - 4 ( DPP - 4 ) inhibitors may have protective effects in the early stage of atherosclerosis in patients with type 2 diabetes , although similar effects in advanced atherosclerosis were\"."
73, Type2Diabetes, 2060, 2075, "type 2 diabetes", "", "<http://ctro/data#ClinicalTrial_76348> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Type2Diabetes>."
83462, DisorderOrSyndrome, 2115, 2130, "atherosclerosis", "", 
176, ObjectiveDescription, 2136, 2197, "not shown in recent randomized placebo - controlled studies .", "", "<http://ctro/data#ClinicalTrial_76348> <http://ctro/data#hasObjectiveDescription> \"not shown in recent randomized placebo - controlled studies .\"."
75, Randomized, 2156, 2166, "randomized", "", 
76, Placebo, 2167, 2174, "placebo", "", 
174, ObjectiveDescription, 2198, 2345, "Therefore , we investigated the efficacy of DPP - 4 inhibitor on endothelial function and glycemic metabolism compared with high - dose metformin .", "", "<http://ctro/data#ClinicalTrial_76348> <http://ctro/data#hasObjectiveDescription> \"Therefore , we investigated the efficacy of DPP - 4 inhibitor on endothelial function and glycemic metabolism compared with high - dose metformin .\"."
77, Metformin, 2334, 2343, "metformin", "", 
79, Multicenter, 2364, 2375, "multicenter", "", "<http://ctro/data#ClinicalTrial_76348> <http://ctro/data#hasCTDesign> <http://ctro/data#Multicenter>."
80, OpenLabel, 2378, 2392, "open - labeled", "", "<http://ctro/data#ClinicalTrial_76348> <http://ctro/data#hasCTDesign> <http://ctro/data#OpenLabel>."
81, Prospective, 2395, 2406, "prospective", "", "<http://ctro/data#ClinicalTrial_76348> <http://ctro/data#hasCTDesign> <http://ctro/data#Prospective>."
82, Randomized, 2409, 2419, "randomized", "", 
83, Parallel, 2422, 2438, "parallel - group", "", "<http://ctro/data#ClinicalTrial_76348> <http://ctro/data#hasCTDesign> <http://ctro/data#Parallel>."
88, Precondition, 2458, 2546, "patients with type 2 diabetes treated with low - dose metformin ( 500 - 750   mg / day )", "", "<http://ctro/data#Population_76364> <http://ctro/data#hasPrecondition> \"patients with type 2 diabetes treated with low - dose metformin ( 500 - 750   mg / day )\"."
74, Type2Diabetes, 2472, 2487, "type 2 diabetes", "", 
84, Metformin, 2512, 2521, "metformin", "", "<http://ctro/data#Medication_76415> <http://ctro/data#hasDrug> <http://ctro/data#Metformin>. <http://ctro/data#Medication_76422> <http://ctro/data#hasDrug> <http://ctro/data#Metformin>."
85, DoseValue, 2524, 2533, "500 - 750", "", "<http://ctro/data#Medication_76415> <http://ctro/data#hasDoseValue> \"500 - 750\". <http://ctro/data#Medication_76422> <http://ctro/data#hasDoseValue> \"500 - 750\"."
86, mg, 2536, 2538, "mg", "", "<http://ctro/data#Medication_76415> <http://ctro/data#hasDoseUnit> <http://ctro/data#mg>. <http://ctro/data#Medication_76422> <http://ctro/data#hasDoseUnit> <http://ctro/data#mg>."
83469, Interval, 2541, 2544, "day", "", "<http://ctro/data#Intervention_76396> <http://ctro/data#hasInterval> \"day\". <http://ctro/data#Intervention_76402> <http://ctro/data#hasInterval> \"day\"."
89, Randomized, 2565, 2573, "randomly", "", 
3, Vildagliptin, 2588, 2600, "vildagliptin", "", "<http://ctro/data#Medication_76408> <http://ctro/data#hasDrug> <http://ctro/data#Vildagliptin>."
14, Vildagliptin, 2642, 2647, "Vilda", "", 
214, DoseDescription, 2655, 2666, "double dose", "", "<http://ctro/data#Medication_76422> <http://ctro/data#hasDoseDescription> \"double dose\"."
9, Metformin, 2670, 2679, "metformin", "", 
189, Metformin, 2693, 2696, "Met", "", 
90, Duration, 2703, 2713, "12   weeks", "", "<http://ctro/data#ClinicalTrial_76348> <http://ctro/data#hasCTduration> \"12   weeks\"."
201, EndPointDescription, 2716, 2740, "Flow - mediated dilation", "", 
202, EndPointDescription, 2743, 2746, "FMD", "", 
92, NumberPatientsCT, 2907, 2921, "Ninety - seven", "", "<http://ctro/data#ClinicalTrial_76348> <http://ctro/data#hasNumberPatientsCT> \"Ninety - seven\"."
93, AvgAge, 2938, 2944, "58 . 7", "", "<http://ctro/data#Population_76364> <http://ctro/data#hasAvgAge> \"58 . 7\"."
194, Year, 2958, 2963, "years", "", 
94, BMI, 2966, 2981, "body mass index", "", 
95, BaseLineValue, 2984, 2990, "25 . 9", "", 
96, SdDevBL, 2995, 3000, "4 . 4", "", 
97, Kg_per_squareMeter, 3003, 3010, "kg / m2", "", 
98, HbA1c, 3013, 3018, "HbA1c", "", 
99, BaseLineValue, 3021, 3026, "7 . 3", "", "<http://ctro/data#Outcome_76456> <http://ctro/data#hasBaselineValue> \"7 . 3\". <http://ctro/data#Outcome_76483> <http://ctro/data#hasBaselineValue> \"7 . 3\"."
100, SdDevBL, 3031, 3036, "0 . 5", "", "<http://ctro/data#Outcome_76456> <http://ctro/data#hasSdDevBL> \"0 . 5\". <http://ctro/data#Outcome_76483> <http://ctro/data#hasSdDevBL> \"0 . 5\"."
101, Percentage, 3037, 3038, "%", "", 
102, EndPointDescription, 3041, 3044, "FMD", "", "<http://ctro/data#EndPointDescription_76520> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_76519> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_76520>."
103, BaseLineValue, 3047, 3052, "5 . 8", "", "<http://ctro/data#Outcome_76524> <http://ctro/data#hasBaselineValue> \"5 . 8\". <http://ctro/data#Outcome_76551> <http://ctro/data#hasBaselineValue> \"5 . 8\"."
104, SdDevBL, 3057, 3062, "2 . 6", "", "<http://ctro/data#Outcome_76524> <http://ctro/data#hasSdDevBL> \"2 . 6\". <http://ctro/data#Outcome_76551> <http://ctro/data#hasSdDevBL> \"2 . 6\"."
105, Percentage, 3063, 3064, "%", "", "<http://ctro/data#Endpoint_76519> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Percentage>."
106, NumPatientsLeftCT, 3083, 3088, "Eight", "", "<http://ctro/data#ClinicalTrial_76348> <http://ctro/data#hasNumPatientsLeftCT> \"Eight\"."
242, TimePoint, 3200, 3208, "baseline", "", 
107, TimePoint, 3233, 3243, "12   weeks", "", 
108, HbA1c, 3246, 3251, "HbA1c", "", "<http://ctro/data#Endpoint_76451> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c>."
5, Vildagliptin, 3286, 3291, "Vilda", "", 
212, Metformin, 3321, 3324, "Met", "", 
109, Reduction, 3336, 3342, "0 . 80", "", "<http://ctro/data#Outcome_76456> <http://ctro/data#hasChangeValue> \"0 . 80\"."
111, SdDevChangeValue, 3347, 3353, "0 . 38", "", "<http://ctro/data#Outcome_76456> <http://ctro/data#hasSdDevChangeValue> \"0 . 38\"."
113, Percentage, 3354, 3355, "%", "", "<http://ctro/data#Endpoint_76451> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Percentage>."
110, Reduction, 3364, 3370, "0 . 40", "", "<http://ctro/data#Outcome_76483> <http://ctro/data#hasChangeValue> \"0 . 40\"."
112, SdDevChangeValue, 3375, 3381, "0 . 47", "", "<http://ctro/data#Outcome_76483> <http://ctro/data#hasSdDevChangeValue> \"0 . 47\"."
114, Percentage, 3382, 3383, "%", "", 
115, PvalueDiff, 3401, 3413, "p  <  0 . 01", "", "<http://ctro/data#DiffBetweenGroups_76510> <http://ctro/data#hasPvalueDiff> \"p  <  0 . 01\"."
116, EndPointDescription, 3469, 3472, "FMD", "", 
117, Reduction, 3478, 3484, "0 . 51", "", "<http://ctro/data#Outcome_76524> <http://ctro/data#hasChangeValue> \"0 . 51\"."
119, ConfIntervalChangeValue, 3485, 3504, "[-  1 . 08 - 0 . 06", "", "<http://ctro/data#Outcome_76524> <http://ctro/data#hasConfIntervalChangeValue> \"[-  1 . 08 - 0 . 06\"."
121, Percentage, 3507, 3508, "%", "", 
118, Reduction, 3517, 3523, "0 . 58", "", "<http://ctro/data#Outcome_76551> <http://ctro/data#hasChangeValue> \"0 . 58\"."
120, ConfIntervalChangeValue, 3524, 3543, "[-  1 . 20 - 0 . 04", "", "<http://ctro/data#Outcome_76551> <http://ctro/data#hasConfIntervalChangeValue> \"[-  1 . 20 - 0 . 04\"."
122, Percentage, 3546, 3547, "%", "", 
123, EndPointDescription, 3565, 3607, "apolipoprotein B / apolipoprotein A1 ratio", "", "<http://ctro/data#EndPointDescription_76579> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_76578> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_76579>."
125, ObservedResult, 3608, 3675, "was significantly reduced in the Vilda group compared with baseline", "", 
4, Vildagliptin, 3641, 3646, "Vilda", "", 
124, TimePoint, 3667, 3675, "baseline", "", 
227, BaseLineValue, 3678, 3684, "0 . 66", "", "<http://ctro/data#Outcome_76583> <http://ctro/data#hasBaselineValue> \"0 . 66\"."
228, ResultMeasuredValue, 3687, 3693, "0 . 62", "", "<http://ctro/data#Outcome_76583> <http://ctro/data#hasResultMeasuredValue> \"0 . 62\"."
127, PValueChangeValue, 3696, 3708, "p  <  0 . 01", "", "<http://ctro/data#Outcome_76583> <http://ctro/data#hasPValueChangeValue> \"p  <  0 . 01\"."
128, Reduction, 3781, 3787, "0 . 04", "", "<http://ctro/data#Outcome_76583> <http://ctro/data#hasChangeValue> \"0 . 04\"."
129, NoChange, 3793, 3799, "0 . 00", "", "<http://ctro/data#Outcome_76610> <http://ctro/data#hasChangeValue> \"0 . 00\"."
130, PvalueDiff, 3802, 3814, "p  =  0 . 27", "", "<http://ctro/data#DiffBetweenGroups_76664> <http://ctro/data#hasPvalueDiff> \"p  =  0 . 27\"."
131, EndPointDescription, 3819, 3830, "Adiponectin", "", "<http://ctro/data#EndPointDescription_76674> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_76673> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_76674>."
6, Vildagliptin, 3874, 3879, "Vilda", "", 
234, Metformin, 3909, 3912, "Met", "", 
132, Increment, 3921, 3927, "0 . 75", "", "<http://ctro/data#Outcome_76678> <http://ctro/data#hasChangeValue> \"0 . 75\"."
134, BioAndMedicalUnit, 3928, 3937, " μ g / mL", "", "<http://ctro/data#BioAndMedicalUnit_76676> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit>. <http://ctro/data#Endpoint_76673> <http://ctro/data#hasBaselineUnit> <http://ctro/data#BioAndMedicalUnit_76676>."
133, Increment, 3943, 3949, "0 . 01", "", "<http://ctro/data#Outcome_76705> <http://ctro/data#hasChangeValue> \"0 . 01\"."
135, BioAndMedicalUnit, 3950, 3959, " μ g / mL", "", 
136, PvalueDiff, 3962, 3974, "p  <  0 . 01", "", "<http://ctro/data#DiffBetweenGroups_76732> <http://ctro/data#hasPvalueDiff> \"p  <  0 . 01\"."
138, ConclusionComment, 3993, 4185, "Regardless of glycemic improvement , combination therapy of vildagliptin and metformin did not affect endothelial function but may exert favorable effects on adipokine levels and lipid profile", "", "<http://ctro/data#ClinicalTrial_76348> <http://ctro/data#hasConclusionComment> \"Regardless of glycemic improvement , combination therapy of vildagliptin and metformin did not affect endothelial function but may exert favorable effects on adipokine levels and lipid profile\"."
7, Vildagliptin, 4053, 4065, "vildagliptin", "", 
13, Metformin, 4070, 4079, "metformin", "", 
139, ConclusionComment, 4186, 4253, "in patients with type 2 diabetes without advanced atherosclerosis .", "", "<http://ctro/data#ClinicalTrial_76348> <http://ctro/data#hasConclusionComment> \"in patients with type 2 diabetes without advanced atherosclerosis .\"."
137, Type2Diabetes, 4203, 4218, "type 2 diabetes", "", 
140, PMID, 4322, 4330, "29017497", "", "<http://ctro/data#Publication_76341> <http://ctro/data#hasPMID> \"29017497\"."
